Clinical Trials Directory

Trials / Completed

CompletedNCT04344327

Early Risk Stratification of Patient Hospitalized for SARS-CoV2 Infection: Critical COVID-19 France CCF

Status
Completed
Phase
Study type
Observational
Enrollment
2,878 (actual)
Sponsor
French Cardiology Society · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The COVID-19 pandemic of SARS CoV2 (Severe Acute Respiratory Syndrome, COVID-19) infection, which is currently evolving in France, raises many questions about the clinical and biological profile of infected hospitalized patients. If certain biological factors like troponin, BNP (Brain Natriuretic Peptid), or clinical factors like cardiovascular history or oncological history are associated with a worse prognosis, available data comes from studies in Asia for the majority, or including a limited number of patients. Patient stratification remains a major issue for patient sorting and early referral of patients.

Detailed description

This study is observational, multicenter and retrospective, and is conducted in hospitals in France. Clinical data relating to history, comorbidities, risk factors, previous treatments, treatments during the hospitalization and treatments at the discharge from hospital, clinical parameters, biological and ultrasound cardiological data, procedures and events during hospitalization will be recorded, in order to identify the early predictors of clinical worsening in patients hospitalized for COVID-19 in cardiology or conventional medicine department.

Conditions

Timeline

Start date
2020-04-10
Primary completion
2020-04-21
Completion
2020-04-21
First posted
2020-04-14
Last updated
2020-04-28

Locations

23 sites across 1 country: France

Source: ClinicalTrials.gov record NCT04344327. Inclusion in this directory is not an endorsement.